Cargando…

Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?

Detalles Bibliográficos
Autores principales: Ben Dhia, A., Hamzaoui, S., Mouaffak, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166252/
https://www.ncbi.nlm.nih.gov/pubmed/32317164
http://dx.doi.org/10.1016/j.encep.2020.04.001
_version_ 1783523520881360896
author Ben Dhia, A.
Hamzaoui, S.
Mouaffak, F.
author_facet Ben Dhia, A.
Hamzaoui, S.
Mouaffak, F.
author_sort Ben Dhia, A.
collection PubMed
description
format Online
Article
Text
id pubmed-7166252
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher L'Encéphale, Paris.
record_format MEDLINE/PubMed
spelling pubmed-71662522020-04-20 Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi? Ben Dhia, A. Hamzaoui, S. Mouaffak, F. Encephale Article L'Encéphale, Paris. 2020-06 2020-04-03 /pmc/articles/PMC7166252/ /pubmed/32317164 http://dx.doi.org/10.1016/j.encep.2020.04.001 Text en © 2020 L'Encéphale, Paris. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ben Dhia, A.
Hamzaoui, S.
Mouaffak, F.
Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title_full Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title_fullStr Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title_full_unstemmed Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title_short Epidémie au nouveau coronavirus (SARS-CoV-2) et prescription de la clozapine: quelles mesures? Pourquoi?
title_sort epidémie au nouveau coronavirus (sars-cov-2) et prescription de la clozapine: quelles mesures? pourquoi?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166252/
https://www.ncbi.nlm.nih.gov/pubmed/32317164
http://dx.doi.org/10.1016/j.encep.2020.04.001
work_keys_str_mv AT bendhiaa epidemieaunouveaucoronavirussarscov2etprescriptiondelaclozapinequellesmesurespourquoi
AT hamzaouis epidemieaunouveaucoronavirussarscov2etprescriptiondelaclozapinequellesmesurespourquoi
AT mouaffakf epidemieaunouveaucoronavirussarscov2etprescriptiondelaclozapinequellesmesurespourquoi